Navigation Links
Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
Date:3/3/2009

New Technology Used to Treat Abnormal Heart Rhythms

AUSTIN, Texas, March 3 /PRNewswire/ -- On Tuesday, March 3, 2009, the Texas Cardiac Arrhythmia Institute at St. David's Medical Center became the first in the United States to utilize the long-awaited NaviStar(R) RMT ThermoCool(R) Catheter to treat abnormal heart rhythms, or arrhythmias, since the new technology received FDA approval on Friday, Feb. 27, 2009.

The NaviStar(R) RMT ThermoCool(R) Catheter for radiofrequency (RF) ablation is used with the NIOBE(R) Magnetic Navigation System, which helps steer a catheter remotely and guide ablation to targeted areas that require treatment.

An irregular rhythm in the left upper chamber of the heart or atrial fibrillation is the most common arrhythmia. Like other catheters, the NaviStar(R) RMT ThermoCool(R) Catheter uses heat to destroy abnormal heart muscle that causes atrial fibrillation. The new technology is unique because it sprays cooled saline. Physicians say it is safer and more effective than previous catheters and poses fewer risks for complications.

The NaviStar(R) RMT ThermoCool(R) Catheter maintains a temperature of no more than 42 degrees Celsius while ablation energy is being delivered to the heart tissue. Previously, the temperature at the tip of the catheter reached 65 degrees Celsius, which could cause blood clots on the heart tissue.

"The NaviStar(R) RMT ThermoCool(R) Catheter is revolutionary to the treatment of irregular heart rhythms," said Andrea Natale, M.D., F.A.C.C., F.H.S., executive director of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center and the electrophysiologist who performed the procedure. "The fact that the Texas Cardiac Arrhythmia Institute is the first in the United States to employ this leading-edge technology is proof that we are on the forefront of treatment for heart arrhythmias."

The Texas Cardiac Arr
'/>"/>

SOURCE Texas Cardiac Arrhythmia Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Motor behavioral research at UH moves to prestigious Texas Medical Center
2. New Texas Study Reveals Serious Flaws in Abstinence Programs
3. Texas Association of Health Underwriters Announces 15th Annual Day at the Capitol
4. Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession
5. University of Texas engineers receive $3.2 million in National Science Foundation CAREER awards
6. Accordent Delivers Medical Lecture Capture Platform for University of Texas Health Sciences Center
7. Texas Mutual Wins National Employee Wellness Award
8. New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia
9. Texas Health Dallas New Intensivist Program Puts Critical-Care Specialists in the ICU - All the Time
10. High-tech Texas hospitals see fewer complications, lower costs, UT Southwestern researcher finds
11. Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... and Crushing Taxes Nail Nation,s Job Creators ,...n response to U.S. House passage of the health car...eurship Council (SBE Council) president & CEO ..., "Make no mistake, those voting for H.R. 3962 v...er costs and crushing taxes and penalties. Even in...
(Date:11/8/2009)... Freeze-drying of biopharmaceuticals to be ...rio facility. , Toronto,...esident and CEO of Therapure Biopharma Inc. today ... commercial scale pharmaceutical grade freeze drye...ng (lyophilization) available for contract manufac...
(Date:11/8/2009)...rgest network of Hispanic health advocates committ...009 ,, WASHINGTON, Nov. 7 /PRNewswire-USNewswi...showed they have heard the voice of America,s fami...rica Act. Now the Senate must deliver, without del...m," said Dr. Jane L. Delgado, President and CEO of...
(Date:11/8/2009)...s House Passage of Health Care Reform Bill ,, ...mprove coverage for all Americans ,, CHICAGO, ...d States House of Representatives passed by a vote...on that would strengthen Medicare for seniors and ...ces millions of Americans out of affordable health...
(Date:11/7/2009)... Nov. 7 Speaker Nanc... of H.R. 3962, the Affordable Health Care for Amer...ater tonight. Below are the Speaker,s remarks. ,...historic moment for our nation and for American fa...rty and political philosophy -- as far back as Ted...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...ing sucrose to reduce pain in newborns undergoing ...ing blood taken (venipuncture) for the newborn scr...write Dr. Anna Taddio and co-authors. , In this ...ewborns when administered before painful medical p...
...-Topping Recording Artist Has Partnered with Music...port of the Heightened National Response to ...une 30 Platinum selling,singer/songwriter/produce...ur, Lyfe is partnering with Music World,Entertainm...
...: THE (mostly) BIG THOUGHTS EDITION (p. 26). In th...tions, collects factoids and writes essays,on topi... whether having,children makes you happier and whe...overed in the issue. Try these:, 1. How many pres...
... Americans die each year waiting for a replacement... 29 (HealthDay News) -- More than 98,000 Americans...only chance for survival is a dead person,s genero...for a replacement organ that never arrived, accord...
...E, Calif., June 28 Western Growers is,urging the ... soon as,possible on the salmonella outbreak that ... plum tomatoes., FDA and CDC have been unable to ...ing irreparable harm., "Congress must investigate...
...anadian study finds increase in non-serious side e... -- Drugs that contain compounds called cannabinoi...k of serious side effects but are associated with ...tish Columbia (UBC) examined adverse events report...
Other Medicine News:Health News:Lyfe Jennings Launches Summer Tour and HIV/AIDS Awareness Initiative 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 3Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 4Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 5Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 2Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 3Health News:Western Growers Asks for Congressional AG Committee Hearings Regarding Salmonella Outbreak and Investigations 2Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2
(Date:11/6/2009)...,, - Trial Will Compare NXL103 With Leading...esistant Staphylococcus Aureus (MRSA) Infections ,...pany focused on the discovery and,development of n...ant global,problem of microbial resistance, announ...l NXL103 (flopristin/linopristin), has started a P...
(Date:11/5/2009)...ea Technologies, Inc., a leading provider of devel...tical products announced the addition of customize...m of services, which will be overseen by the newly...tion Development. This investment in an experience...long with new laboratory facilities and state-of-t...
(Date:11/5/2009)...stCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" ...trial of Topical Interferon Alpha-2b for the treat...ent enrollment, with the required 120th patient ra...d and placebo-controlled Phase II trial is underwa...ents participating in the trial self-administer ac...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 1Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 2BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 1BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 2BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 3Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 1Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 2Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 3
...d YONGIN, South Korea, Jan. 12 Jennerex,Inc. (San... Korean partner,Green Cross Corp., today announced... primary liver cancer clinical trial using its tar...xicities were reported, and enrollment of,patients...rial involves treatment of patients with advanced,...
... 12 Cara Therapeutics, Inc. today announced that ...long-acting peripheral kappa opioid agonist, CR845...-controlled trial will be conducted in the United ...d safety of intravenous CR845 during the post-oper...ted hysterectomy. The trial is expected to enroll ...
Other Medicine Technology:Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 2Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 3Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 4Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain 2
27 Gauge Air Injection Cannula
Reverse Double Barreled Irrigation/Aspiration Set
Irrigation/Aspiration Cannula
Infusion Lens Loop
Medicine Products: